Neurocognitive ability is a fundamental readout of brain function, and cognitive deficits are a critical component of neuropsychiatric disorders, yet neurocognition is poorly understood at the molecular level. In the present report, we present the largest genome-wide association studies (GWAS) of cognitive ability to date (N=107,207), and further enhance signal by combining results with a large-scale GWAS of educational attainment. We identified 70 independent genomic loci associated with cognitive ability, 34 of which were novel. A total of 350 genes were implicated, and this list showed significant enrichment for genes associated with Mendelian disorders with an intellectual disability phenotype.
Introduction
Genome-wide association studies (GWAS) have been highly successful at uncovering hundreds of genetic loci associated with heritable quantitative traits such as height 1 and weight 2 (body mass index). However, identifying genetic loci underlying cognitive ability has been much more challenging, despite comparably high levels of heritability as determined by both classical twin studies 3 and molecular genetic studies 4 . Uncovering the molecular genetic basis of individual differences in cognitive performance can have a significant impact on our understanding of neuropsychiatric disorders, which are both phenotypically [5] [6] [7] [8] and genetically [9] [10] [11] correlated with cognition, as well as numerous nonpsychiatric health-relevant phenotypes 12 that also are significantly genetically correlated with cognitive function.
In part, the difficulty with cognitive GWAS may be caused by the relative degree of heterogeneity in the measurement of the cognitive phenotype. Traditionally, general cognitive ability (g) has been defined as a latent trait underlying shared variance across multiple subdomains of cognitive performance, psychometrically obtained as the first principal component of several distinct neuropsychological test scores 13 . Using this approach, several cognitive GWAS with fewer than 20,000 subjects yielded no genome-wide significant (GWS) effects 4, 9, 14 , while a few GWS loci were identified in large GWAS of 35, 298 15 subjects and 53,949 16 subjects, respectively. Notably, these efforts involved meta-analysis across cohorts using different sets of cognitive tests to derive the principal component score, which may have reduced power. By contrast, two independent GWAS of height with sample sizes of approximately 30,000 subjects each yielded 20-30 GWS hits 17, 18 ; allelic effect sizes were ~2-5 times larger than the largest obtained in cognitive GWAS 19 .
Given the small effect sizes observed in cognitive GWAS, it has become evident that greatly increased sample sizes will be required to ascend the GWAS yield curve. Very recently, a cognitive GWAS 20 was able to leverage a very brief (two-minute) measure of fluid intelligence, highly correlated with psychometrically defined g, obtained in over 50,000 subjects. In combination with several traditional cognitive GWAS cohorts, total sample size was 78,308. This sample size permitted discovery of 18 independent GWS allelic loci, as well as numerous additional loci from gene-based analysis. This report was critical in demonstrating that signal could be enhanced by combining data from cohorts with brief measures of intelligence with more traditional cognitive GWAS.
Yet another approach to enhancing power in cognitive GWAS has focused on educational attainment as a proxy phenotype 21 . It is acknowledged that this phenotype is 'noisy,' as it is influenced by non-cognitive genetic 22 (e.g., personality) and environmental 23 (e.g., socio-economic) factors; consequently, observed allelic effect sizes have been even smaller than those obtained for GWAS of g 24 .
However, by utilizing a single-item measure (years of education completed), obtained incidentally in large studies of other phenotypes, this approach has allowed investigators to obtain extremely large sample sizes. A recent study of educational attainment in nearly 300,000 individuals identified 74 independent GWS loci 25 . Notably, the genetic correlation between educational attainment and psychometric g is very high, consistently reported in the range of .70-.75 15, 16, 20, 25, 26 .
Thus, cognitive GWAS can be further enhanced by combining information from these large studies of educational attainment with studies of test-based cognitive performance. A new technique called multi-trait analysis of GWAS (MTAG) 27 has been developed which permits integration of GWAS data across related traits, accounting for the possibility of overlapping samples across studies, and requiring only summary statistics. Notably, the developers of MTAG demonstrated its accuracy and utility in a study of traits that also demonstrate genetic correlations in the range of ~.70-.75 (depression, neuroticism, and subjective well-being). MTAG is able to quantify the degree of "boost" to the signal of a single-trait GWAS, providing an estimate of observed sample size, and providing summary statistics (allelic weights) that can then be utilized in all downstream annotation pipelines available for GWAS output.
In the present study, we first utilized GWAS meta-analysis to combine our prior COGENT GWAS 15 of psychometrically defined g with the recently reported GWAS 20 relying primarily on the brief measure, resulting in a combined cohort of N=107,207 non-overlapping samples. Next, we utilized MTAG to combine these results with the large-scale GWAS of educational attainment, resulting in enhanced power. At each step, we performed both allelic and gene-based tests. We then performed downstream analyses on the resulting MTAG summary statistics, including: 1) competitive gene set analyses to identify key biological processes and potential drug targets implicated; 2) stratified linkage disequilibrium score regression (LDSC) to identify differential cell type expression; 3) transcriptome-wide association study (TWAS) methods, to identify specific effects of altered gene expression in the brain on cognition; and 4) LDSC to identify genetic correlations with other anthropometric and biomedical phenotypes.
Results

Fixed Effect Meta-Analysis: Cognitive Performance GWAS
Fixed effect meta-analysis of all non-overlapping cohorts from the two GWAS of cognitive performance (total N = 107,207) identified 28 independent genomic loci reaching genome-wide significance (GWS, p<5E-08), using default clumping parameters from the FUMA 28 pipeline ( Figure 1a ); this represents a 55.6% increase in loci compared to the previous GWAS 20 of cognitive performance.
Two of these loci each contained two uncorrelated variants with independent effects, resulting in 30 independent lead SNPs. As demonstrated in the QQ plot ( Supplementary Figure 1) , statistical inflation was quite modest for a large study of a highly polygenic trait (λ=1.23; λ1000=1.001; LD score intercept=1.03), and overall SNP heritability was .168. Of the 28 GWS loci, 12 are novel and not previously reported as GWS in published studies of cognitive or educational phenotypes (Supplementary Table 2 ). The majority of the 5,610 markers reaching a nominal significance threshold were intronic SNPs followed by those in the intergenic regions (Supplementary Table 3 and Supplementary Figure 2 ). As shown in Supplementary Table 4 , several of the GWS loci overlap with loci related to schizophrenia, bipolar disorder, and other neuropsychiatric phenotypes, as well as obesity/body mass index and other traits.
The significant loci harbored 88 known protein coding genes ( Supplementary Table 5 ), about half of which were in three large regions ( Supplementary Figure 3) , including two well-characterized regions: the distal 16p11.2 region, in which deletions have been associated with schizophrenia and other neuropsychiatric phenotypes 29 , and the 17q21 region, in which inversions have been associated with neuropsychiatric disorders 30, 31 . Using MAGMA 32 gene-based tests, 73 genes were genome-wide significant ( Supplementary Figure 4 ; Supplementary Table 6 ), of which 39 were overlapping with the 88 genes noted above, resulting in a total of 122 genes with GWS evidence of association to cognitive performance.
MTAG: Combining Cognitive Performance and Educational Attainment GWAS
MTAG analysis combining the cognitive performance results obtained above with the large education attainment GWAS previously reported 25 , resulted in a 75% enrichment of statistical power, effectively boosting the original sample size of N = 107,207 to a GWAS equivalent of N = 187,812 ( Table   1 ). Default clumping procedures revealed that 70 independent genomic loci reached genome-wide significance, with 82 independent SNPs (Figure 1b ). Similar to the GWAS results above, the QQ plot (Supplementary Figure 5 ), demonstrated polygenicity without substantial statistical inflation (λ=1.28; λ1000=1.001; LD score intercept=0.91), and overall SNP heritability was 0.336. Of the 70 GWS loci, 34 are novel and not previously reported as GWS in published studies of cognitive or educational phenotypes ( Figure 2 ; Supplementary Table 7 ). The majority of the 13,549 SNPs reaching a nominal significance threshold were intergenic or intronic (Supplementary Table 8 ; Supplementary Figures 6 & 7) . As is typically the case in GWAS, few significant SNPs were exonic; GWS variants causing protein-coding changes rated as damaging by either Polyphen or SIFT are listed in Supplementary Table 9 . Variants in only four genes demonstrated converging evidence for being damaging to protein structure: three at chromosome 17q21.31 (KANSL1, MAPT, and SPPL2C), as well as one at chromosome 3p21.31 (MST1). Supplementary Table 10 .
GWAS catalog annotations are listed in
Within the GWS loci, 267 protein coding genes were identified ( Supplementary Table 11 ).
Additionally, 257 genes were significant in MAGMA gene-based tests ( Supplementary Figure 8 ; Supplementary Table 12 ); of these, 83 genes were non-overlapping with the 267 genes with SNP GWS loci, resulting in a total of 350 genes receiving GWS support from the MTAG results. We compared this list of 350 genes with a list of 621 genes known to cause autosomal dominant or autosomal recessive Mendelian disorders featuring intellectual disability 33, 34 . As shown in Table 2 , a total of 23 genes identified by MTAG appeared on this list, representing a 2-fold enrichment over chance (p=0.001).
As a formal validation that the MTAG methodology successfully predicts phenotype variance for cognitive performance, MTAG was re-analyzed, excluding the ASPIS and GCAP datasets from the COGENT cohorts; these datasets were held out as target cohorts used for calculation of polygenic risk score modelling for "g". Despite the relatively small size of these hold-out cohorts, results show strongly significant polygenic prediction of "g" using MTAG-derived allele weights ( Supplementary Figures 9 and   10 ), accounting for more than 4% of the variance in the GCAP cohort. For both cohorts, polygenic prediction began to drop at PT thresholds above 0.05, suggesting that there may be some degree of saturation of signal beyond the nominal 0.05 significance level.
Gene Expression and Competitive Pathway Analysis
Downstream MAGMA expression profiles and competitive pathway analysis were conducted as part of the FUMA pipeline. MAGMA tissue expression profile analysis revealed that genes emerging from the MTAG analysis were significantly enriched for expression in nearly all central nervous system tissues (except for substantia nigra and spinal cord), and that this enrichment was exclusive to neural tissues ( Figure 3) . Notably, the strongest enrichment was observed for genes expressed in the cerebellum, followed by cortex, and slightly weaker (but still strongly significant) enrichment in subcortical and limbic structures.
Competitive pathway analysis (based on gene ontology categories) for GWS MAGMA genes identified by MTAG revealed significant enrichment of neuronal and synaptic cellular components, as well as the biological process of neurogenesis (Table 3a) . Competitive pathway analysis for drug pathways 35 revealed that two drugs were significantly associated with the MTAG results (Table 3b) :
Cinnarizine, a T-type calcium channel blocker and LY97241, a potassium channel inhibitor. L-type calcium channel blockers and anti-inflammatories also showed suggestive evidence of enrichment.
Stratified LD score regression 36 also demonstrated an enrichment of cell type expression for neuronal tissues only. Notably, genes found in the neuronal expression list of Cahoy 37 were significantly enriched (p=.0129; Bonferroni-corrected p=.0386), whereas negative results were obtained for genes expressed in oligodendrocytes (p=.4997) and astrocytes (p=.9057). Additionally, using Roadmap annotations, epigenetic enrichment was strongest in fetal brain tissue DNase sites and H3K4me1 primed enhancers; followed by adult cortical H3K27ac active enhancer sites (see Supplementary Table 13 for further details). No enrichment was observed in any non-neuronal tissue.
Transcriptomic Wide Analysis and Brain Expression Lookups
We performed transcriptome-wide analysis (TWAS, using MetaXcan 38 with GTEx reference data) on MTAG-derived SNP summary statistics in order to determine whether up-or down-regulation of specific transcripts in specific neural compartments were associated with cognition. (TWAS follows a similar logic to imputation, in that an external reference (in this case, GTEx) is utilized to link available SNP data to tissue-based, gene expression levels.) Several strong transcriptomic associations were specific to individual brain regions such as hippocampus, cortex, or cerebellum. For example, the strongest result in hippocampus was with DAG1; TWAS demonstrated that greater expression of this gene in hippocampus was associated with higher cognitive scores. However, this gene was not significantly associated in analyses of other neural tissue types. Similarly, lower levels of ACTR1A are associated with cognition, but only in frontal cortex. However, as shown in Supplementary Table 14 , most of the strongest TWAS results are tissue non-specific, involving genes such as AMIGO3, RNF123, and RBM6 (Supplementary 
Genetic Correlations with Other Phenotypes
LD-score regression was carried out across 98 traits in 15 broad phenotypic categories in LD-hub 41 : 1) aging, 2) anthropometric, 3) autoimmune, 4) brain volume, 5) cardiometabolic, 6) education, 7) gycemic, 8) lipids, 9) lung function, 10) neurological, 11) personality, 12) psychiatric, 13) reproductive behavior, 14) sleeping, and 15) smoking behavior. Cognition appeared to be strongly associated with aging, education, personality, neuropsychiatric disorders, reproductive behavior, and smoking behavior.
Strong association with parental age at death was observed for both the GWAS and MTAG results.
Meanwhile, moderate associations with anthropometric traits were observed, although associations with brain volumes were surprisingly modest, except for total intracranial volume (rg for MTAG results = 0.31). While many of these correlations have been reported previously 12, 15, 20, 25 , two novel results were observed in the present study. First, we report a strong positive genetic correlation between cognitive variables and maternal age at first birth (rg for MTAG results = 0.63, p=2.36E-163) and inverse correlation with parental number of children ever born (rg for MTAG results = -0.2159; p=6.91E-13). It is possible that these effects are mediated by years of higher education, insofar as correlations were even stronger with educational attainment (rg for age at first birth=0.7207, p=2.24E-244; rg for number of children= -0.2623, p=3.34E-18). Second, we observed modest, yet nominally significant, inverse correlations between cognition and autoimmune diseases such as eczema and Crohn's disease, attaining
Bonferroni significance for rheumatoid arthritis (rg for MTAG results = -0.2086; p=1.60E-08); there was also a Bonferroni-significant positive genetic correlation with celiac disease (rg for MTAG results = 0.1922; p=0.0001). While results of cross-trait analyses were largely consistent using either the GWAS results, the MTAG results, or the previously-published educational attainment results, there were notable divergences in correlations with psychiatric phenotypes, especially schizophrenia and bipolar disorder.
Discussion
Here, we have presented the largest GWAS of cognition to date, with 107,207 individuals phenotypically characterized for performance on standardized tests measuring general cognitive ability. Results were further enhanced by utilizing a novel approach to allow further meta-analysis with a large-scale GWAS of educational attainment, which is highly (though not perfectly) correlated with cognitive ability at the genetic level. With this approach, we were able to identify 70 genomic loci significantly associated with cognition, nearly half of which were novel, and ultimately implicated 350 genes underlying cognitive ability. In total, we found that common SNPs were able to account for nearly half of the overall heritability of the phenotype as determined by prior family studies 42 .
Downstream analysis confirmed an important role for neurodevelopmental processes in cognitive ability, consistent with implications from the GWAS of educational attainment 25 . Significant genes were more strongly enriched for expression in fetal brain tissue than adult tissue; results were also enriched for genes implicated in early neurodevelopmental disorders; and neurogenesis was the most strongly enriched GO biological process. At the same time, it is important to emphasize that adult neural tissues were also strongly represented in the results, and multiple synaptic components were significant in the pathway analysis. In this context, it is noteworthy that many cellular processes necessary for early neurodevelopment are also involved in adult synaptic plasticity. This duality is represented by several significant genes emerging from our analysis: CELSR3 encodes an atypical cadherin plasma membrane protein involved in long-range axon guidance in neurodevelopment through planar cell polarity signaling 43 , but is also necessary for adult formation of hippocampal glutamatergic synapses 44 . Similarly, SEMA3F is a negative regulator of dendritic spine development in adult hippocampus 45 , but embryonically serves as an endogenous chemorepellent, guiding septohippocampal fibers away from non-limbic regions of developing cortex 46 .
To our knowledge, this is the first study of cognition to employ TWAS methodology, which was developed with the hope of isolating expression effects of specific genes within broad GWAS loci. In the present study, a few such genes were isolated, such as ACTR1A. This gene, which lies near the GWAS peak at chromosome 10q24, encodes a microtubular dynactin protein involved in retrograde axon transport 47 ; other genes at this locus were not significant in the TWAS analysis (although a role in cognition cannot be ruled out, given the limited sample size in the reference brain expression datasets in GTEx). However, most of the genes implicated by TWAS were clustered in a few "hot" genomic loci, which may represent topologically associated domains (TADs) under the control of a shared 3dimensional chromatin structure 48, 49 . Whether effects on cognition are driven by all differentially expressed genes within such loci, or if specific effects can be disentangled through experimental means, remains to be determined.
The overlap of 23 genes from our results with known genes for Mendelian disorders characterized by intellectual disability has several implications. First, this statistically significant enrichment provides partial validation of our MTAG results. Second, genes with known mutations of large effect, when combined with our novel data demonstrating SNPs with smaller regulatory effects on the same phenotype (cognition), can be considered an "allelic series" 50 -a natural set of experiments powerfully demonstrating directional information (in the form of a dose-response curve) regarding gene function.
Such information can be leveraged for the identification of novel drug targets. Third, converging evidence across the Mendelian and GWAS lists can aid interpretation of specific pathways and molecular processes that are necessary to normal neuronal function, and vice versa. For example, two genes on both the Mendelian and GWAS lists (GMPPB and LARGE) are associated with dystroglycanopathies with mental retardation. This information provides context for the observation that DAG1, which encodes dystroglycan 1, is the strongest TWAS result in the hippocampus. DAG1 is necessary for GABAergic signaling in hippocampal interneurons 50, 51 . While dystroglycanopathies are most prominently characterized by muscular dystrophy and retinal abnormalities, it is possible that all of these genes play a role in hippocampal synapse formation that is relevant to normal cognitive ability.
As noted above, one of the most important aims of GWAS studies is the identification of novel drug targets, and the drug set enrichment analysis pointed to potential nootropic mechanisms. Most notably, the strongest signal was for cinnarizine, a T-type calcium channel inhibitor typically prescribed for seasickness. In the present study, we discovered a novel association of cognition to CACNA1I, which encodes one component of the voltage-dependent T-Type Cav3.3 channel, and has been previously associated with schizophrenia 52 . While cinnarizine has strong antihistamine activity and may be inappropriate for general cognitive enhancement, a novel agent targeting Cav3.3 has shown nootropic activity in preclinical models. The present study provides supportive evidence for this approach.
It is important to emphasize that uncovering genetic variation underlying general cognitive ability in the healthy population does not have deterministic implications. As has been previously explicated in similar studies, effect sizes for each allele are extremely small (R 2 <0.1% for even the strongest effects), and the combined effects genome-wide predict only a small proportion (~2%-4%) of the total variance in holdout samples ( Supplementary Figures 9 and 10) . Thus, results of the present study do not hold the potential for individual prediction or classification. Nevertheless, results enhance our understanding of molecular mechanisms underlying cognitive ability, illuminating relationships to other health-relevant traits, and pointing towards specific transcriptomic effects and biological pathways that may form the basis of future cognitive enhancement approaches.
Methods
GWAS Quality Control
Markers reported in the prior COGENT study 15 were updated to build 37 coordinates, but imputed against the HRC reference panel 53 via the Sanger imputation server. To ensure that markers, allele frequencies, and alleles are aligned to the 1000 genomes phase 3 reference panel 54 , the COGENT summary statistics 15 were checked using the EasyQC pipeline 55 which allows summary statistics to be aligned and checked against a reference panel of choice. As both fluid intelligence 20 and education 25 summary statistics were imputed to the 1000 genomes phase 3 reference panel, summary statistics were used as provided (URL: https://ctg.cncr.nl/software/summary_statistics; https://www.thessgac.org/data). Further quality control was provided as part of the Multi-trait Analysis for GWAS (MTAG 27 ) pipeline. Alleles were aligned against the first dataset, and only SNPs present across datasets were included in the final analysis. The MTAG quality control pipeline is an adaptation of the 'munge_sumstats' function found in LD score regression 39 .
Fixed Effect Meta-Analysis
Fixed-effect meta-analysis was carried out via METAL 56 . First, fixed-effect meta-analysis was conducted for independent samples reported in the prior COGENT paper 15 that were not included in the GWAS of fluid intelligence 20 . These cohorts are reported in Supplementary Table 1 . The initial metaanalysis resulted in total N = 28,799. Subsequently, further meta-analysis was conducted to combine independent samples from COGENT 15 and fluid intelligence 20 resulting in the combined sample size of N = 107,207 for the cognitive performance meta-analysis. Because the fluid intelligence GWAS utilized the sample-size weighted method to perform meta-analysis across its own cohorts, and did not report variance terms, our meta-analysis was conducted using the sample-size weighted method.
Multi-Trait Analysis for GWAS (MTAG)
To further enrich genetic signals, we employed a newly developed methodology that integrates LDscore genetic regression and meta-analysis techniques across related traits: MTAG 27 . MTAG was applied to the GWAS results applied immediately above, combined with summary statistics from the recent, large-scale educational attainment GWAS 25 . MTAG analysis allows the boosting of genetic signals across related traits, and had been found to be effective in resolving unknown sample overlaps, and generates trait-specific effect estimates weighted by bivariate genetic correlation. The resulting effect estimates and p-values are interpreted in the same manner as single-trait GWAS, which allows standard downstream follow-up analysis on the summary statistics.
Functional Mapping and Annotation for GWAS
GWAS summary statistics from the METAL meta-analysis and MTAG analysis were entered to the Functional Mapping and Annotation (FUMA) pipeline 28 . The FUMA pipeline enables fast prioritization of genomic variants, genes, and interactive visualization of genomic results with respective to state-of-art bioinformatics resources. Manhattan and QQ plots are produced, and MAGMA gene-based analysis is performed, accounting for gene size and LD structure 32 . Competitive gene set analysis using the Molecular Signature Database (MsigDB 5.2), and brain expression databases from GTEX and BrainEAC were also carried in MAGMA as part of the FUMA pipeline. The pipeline also generates aggregated statistics for independent loci, lead SNP, tagged genes, and supplementary plots -including SNP and Loci annotations. Default clumping parameters are GWAS p-value < 5E-08; r2 threshold to define LD structure of lead SNPs > 0.6; maximum P-value cutoff < 0.05; population for clumping = EUR; Minor Allele Frequency filter > 0.01; maximum distance between LD blocks to merge into a locus < 250kb.
Follow-up queries were then made for top independent loci of the cognitive performance metaanalysis as well as the MTAG results and compared against summary statistics for the prior cognitive 20 and education 25 GWAS. For purposes of comparison, loci in which the lead SNPs were within 500kb of each other were considered overlapping. We compared the list of genes resulting from the MTAG analysis (including all genes within GWS SNP loci, as well as GWS genes identified with MAGMA) with a list of 621 genes known to cause autosomal dominant or autosomal recessive Mendelian disorders featuring intellectual disability; this list is primarily derived from a recent comprehensive review 33 , supplemented by a subsequent largescale study of consanguineous multiplex families 34 .
FUMA was also utilized to perform competitive gene-set analyses for GO cell compartment and biological process categories. A separate competitive gene-set analysis was also conducted for the drugbased pathways previously described by Gaspar & Breen 35 .
Polygenic Risk Prediction for independent datasets
To validate that the genetic architecture elucidated via the MTAG methodology, we attempted to predict the phenotypic variance of general cognitive function in two of the independent COGENT cohorts (ASPIS and GCAP). MTAG analysis was conducted as above, but holding out these two cohorts.
All polygenic score prediction was conducted using PRSice 57 .
Stratified LD regression: Cell type Expression and Epigenomics
Functional characterization of GWAS summary statistics were carried out via stratified LD regression to investigate if cognitive heritability is enriched in specific tissue or cell types. Summary statistics were first subjected to baseline partitioned heritability and thereafter passed through cell type functional characterization pipeline 42 . Cell type characterization includes the DEPICT tissue expression, GTEX tissue expression, IMMGEN immune cell types, CAHOY brain level cell types, and the ROADMAP cell epigenomic marks.
Transcriptome Wide Analysis and Brain Expression lookups
Downstream transcriptomic wide analysis and brain expression lookups of top SNPs were carried out to examine if specific genomic regions were exclusive associated with specific or multiple brain regions. Transcriptomic wide analysis is carried out via MetaXcan 43 , which allows for GTEX brain expression mechanisms to be integrated with GWAS summary statistics. Top SNPs obtained from the MTAG GWAS were also subjected to data lookup in the Brain eQTL Almanac (BrainEAC 44 ), as well as CommonMind 45 brain expression datasets. GTEX brain tissue expression profiles include the Anterior Cingulate Cortex; Caudate -Basal Ganglia; Cerebellar Hemisphere; Cerebellum; Cortex; Frontal Cortex; Hippocampus; Hypothalamus; Nucleus Accumbens; and Putamen. BrainEAC top SNP lookups were available for the following tissue expression compartments: CRBL: cerebellum; FCTX: frontal cortex; HIPP: Hippocampus; MEDU: medulla; OCTX: occipital cortex; PUTM: putamen; SNIG: substantia nigra; TCTX: temporal cortex; THAL: thalamus; WHMT: white matter; and aveALL: All areas combined. Only one region (the prefrontal cortex) was available for the CommonMind consortium brain expression profile lookup.
Linkage Disequilibrium Score Regression
LD score regression allows genetic correlations to be computed across traits 58 , which allows further insights to be drawn from understanding the degree to which genetic architecture are shared across traits. To further examine potential traits that overlap with the cognitive architecture from the cognition meta-analysis results and MTAG results, LD score regression was first conducted via the LD-hub pipeline, a centralized trait database 41 . Fifteen broad trait categories were investigated, including: 1) Aging, 2) Anthropometric, 3) Autoimmune, 4) Brain Volume, 5) Cardiometabolic, 6) Education, 7) Glycemic, 8) Lipids, 9) Lung Function, 10) Neurological, 11) Personality, 12) Psychiatric, 13) Reproductive, 14) Sleeping, and 15) Smoking behavior. Very recent results for ADHD 59 and intracranial volume 60 were included as additional phenotypes. The same procedures were also carried out for intelligence and education to investigate how the elucidated genetic architecture for the MTAG results differs from prior published works for education and intelligence. Additional LD score regression analysis was conducted between cognitive phenotypes, to examine the degree of genetic architecture overlap across related cognitive traits. 
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